| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Hélder A. Santos | Q43143343 |
| Nuno Vale | Q44402098 | ||
| P2093 | author name string | Paula Gomes | |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 151-158 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Current Drug Metabolism | Q15724618 |
| P1476 | title | Metabolism of the antituberculosis drug ethionamide | |
| P478 | volume | 14 |
| Q38639630 | A review of the use of ethionamide and prothionamide in childhood tuberculosis |
| Q38837774 | Adverse effects of oral second-line antituberculosis drugs in children. |
| Q39378972 | Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery |
| Q33918580 | Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide |
| Q57342710 | Design and scale-up of an alkylated Minisci reaction to produce ethionamide with 4-cyanopyridine as raw materials |
| Q33599760 | EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide |
| Q99725934 | Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton's Jelly-Derived Mesenchymal Stem Cells |
| Q46480745 | Ethionamide biomimetic activation and an unprecedented mechanism for its conversion into active and non-active metabolites |
| Q36290565 | Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. |
| Q38266496 | Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors as potential antituberculotics: development in the past decade. |
| Q60046884 | Novel Acetamide Indirectly Targets Mycobacterial Transporter MmpL3 by Proton Motive Force Disruption |
| Q38989303 | Recent Advances and Structural Features of Enoyl-ACP Reductase Inhibitors of Mycobacterium tuberculosis |
| Q48331193 | Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance. |
Search more.